相关实验视频

Updated: May 24, 2025

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

解码骨肉瘤的乳基因表达:对预后,免疫动力学和治疗的洞察

Cheng Peng¹, Chaoqun You^1,2, Shuang Cao³

¹Department of Orthopedics, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.

Analytical cellular pathology (Amsterdam)

|March 3, 2025

概括

乳化是骨髓瘤 (OS) 中的一个关键修改,影响瘤生长和患者的生存. 这项研究确定了36个与OS预后和治疗点相关的乳基因.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

骨髓瘤 (OS) 在治疗,转移和耐药性方面存在复杂的挑战.
在OS中的瘤微环境是复杂的,影响治疗结果.
乳化是一种后翻译性修饰,因其在癌症生物学中的作用越来越受认可.

研究的目的:

为了研究乳化对基因表达和瘤行为在骨髓瘤的影响.
分析乳化对OS预后,免疫细胞透和化疗反应的影响.
识别与乳化相关的新型基因作为OS的潜在治疗标.

主要方法:

使用的基因表达总线 (GSE21257) 和TARGET-OS数据集.
分析了267个乳化修饰基因的表达特征.
使用无监督聚类,途径分析和ssGSEA进行免疫细胞透评估.

主要成果:

在OS中确定了36个重要的乳化相关基因,形成了两个不同的群.
一个群体与预后不佳,瘤细胞增多和特定免疫细胞变异相关.
在攻击性OS群中发现了与增强瘤生长和转移相关的基因.

结论:

与乳化相关的基因在骨髓瘤的预后和发病过程中起着重要作用.
这些发现提供了对OS攻击性背后的分子机制的关键见解.
该研究强调了改善OS治疗和患者结果的潜在治疗目标.

关键词:

基因表达的基因表达方式免疫系统现象免疫系统现象骨质肉瘤是骨质肉瘤的一种疾病.预后预后预后瘤微环境是一个微环境.

更多相关视频

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...